Prostate Cancer - Results from #21080

The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases - Abstract March 11, 2014

A surprising diagnosis: Metastatic prostate cancer causing cervical lymphadenopathy - Abstract March 11, 2014

Therapy monitoring of skeletal metastases with whole-body diffusion MRI - Abstract March 10, 2014

Multi-echo gradient recalled echo imaging of the pelvis for improved depiction of brachytherapy seeds and fiducial markers facilitating radiotherapy planning and treatment of prostatic carcinoma - Abstract March 10, 2014

PSA nadir and outcome in 100 patients with pT3b prostate cancer - Abstract March 10, 2014

Metabolic treatment of cancer: Intermediate results of a prospective case series - Abstract March 10, 2014

Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial - Abstract March 10, 2014

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen - Abstract March 10, 2014

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer - Abstract March 10, 2014

Work schedule, sleep duration, insomnia, and risk of fatal prostate cancer - Abstract March 10, 2014

Type 2 diabetes: A protective factor for prostate cancer? An overview of proposed mechanisms - Abstract March 10, 2014

Prostate cancer risk profiles of Asian-American men: Disentangling the effects of immigration status and race/ethnicity - Abstract March 10, 2014

Long-term outcome following radical prostatectomy for Gleason 8-10 prostatic adenocarcinoma - Abstract March 7, 2014

Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer - Abstract March 7, 2014

Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment - Abstract March 7, 2014

Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status - Abstract March 7, 2014

Quantifying cell migration distance as a contributing factor to the development of rectal toxicity after prostate radiotherapy - Abstract March 7, 2014

Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer - Abstract March 7, 2014

Readmission after radical prostatectomy in a nationwide, population-based study - Abstract March 7, 2014

Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session - Abstract March 7, 2014

Page 1055 of 1437